Published in Blood Weekly, February 24th, 2005
P.L. Wang and colleagues recently described this condition in the American Journal of Kidney Diseases. According to their study, "Regional citrate anticoagulation is an alternative to heparin in patients with bleeding diatheses who require CRRT. The short-term metabolic consequences that occur with citrate anticoagulation are well described and usually manageable if established protocols are followed vigilantly. Because of its customary short-term nature, the long-term consequences of CRRT with citrate are less often considered...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.